Schalper KA - Search Results

1

Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.

Viray H, Bradley WR, Schalper KA, Rimm DL, Gould Rothberg BE. Viray H, et al. Among authors: schalper ka. Arch Pathol Lab Med. 2013 Aug;137(8):1063-73. doi: 10.5858/arpa.2012-0284-OA. Arch Pathol Lab Med. 2013. PMID: 23899062 Free PMC article.

2

Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.

Rajbhandari P, Schalper KA, Solodin NM, Ellison-Zelski SJ, Ping Lu K, Rimm DL, Alarid ET. Rajbhandari P, et al. Among authors: schalper ka. Oncogene. 2014 Mar 13;33(11):1438-47. doi: 10.1038/onc.2013.78. Epub 2013 Apr 1. Oncogene. 2014. PMID: 23542176 Free PMC article.

3

High SOX2 levels predict better outcome in non-small cell lung carcinomas.

Velcheti V, Schalper K, Yao X, Cheng H, Kocoglu M, Dhodapkar K, Deng Y, Gettinger S, Rimm DL. Velcheti V, et al. PLoS One. 2013 Apr 19;8(4):e61427. doi: 10.1371/journal.pone.0061427. Print 2013. PLoS One. 2013. PMID: 23620753 Free PMC article.

4

Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1).

Velcheti V, Rimm DL, Schalper KA. Velcheti V, et al. Among authors: schalper ka. J Thorac Oncol. 2013 Jun;8(6):803-5. doi: 10.1097/JTO.0b013e318292be18. J Thorac Oncol. 2013. PMID: 23676558 Free PMC article.

5

Automated objective determination of percentage of malignant nuclei for mutation testing.

Viray H, Coulter M, Li K, Lane K, Madan A, Mitchell K, Schalper K, Hoyt C, Rimm DL. Viray H, et al. Appl Immunohistochem Mol Morphol. 2014 May-Jun;22(5):363-71. doi: 10.1097/PAI.0b013e318299a1f6. Appl Immunohistochem Mol Morphol. 2014. PMID: 24162261 Free PMC article.

6

A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologists criteria.

Schalper KA, Kumar S, Hui P, Rimm DL, Gershkovich P. Schalper KA, et al. Arch Pathol Lab Med. 2014 Feb;138(2):213-9. doi: 10.5858/arpa.2012-0617-OA. Epub 2013 Oct 28. Arch Pathol Lab Med. 2014. PMID: 24164555 Free article.

7

Programmed death ligand-1 expression in non-small cell lung cancer.

Velcheti V, Schalper KA, Carvajal DE, Anagnostou VK, Syrigos KN, Sznol M, Herbst RS, Gettinger SN, Chen L, Rimm DL. Velcheti V, et al. Among authors: schalper ka. Lab Invest. 2014 Jan;94(1):107-16. doi: 10.1038/labinvest.2013.130. Epub 2013 Nov 11. Lab Invest. 2014. PMID: 24217091 Free PMC article.

8

In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas.

Schalper KA, Velcheti V, Carvajal D, Wimberly H, Brown J, Pusztai L, Rimm DL. Schalper KA, et al. Clin Cancer Res. 2014 May 15;20(10):2773-82. doi: 10.1158/1078-0432.CCR-13-2702. Epub 2014 Mar 19. Clin Cancer Res. 2014. PMID: 24647569

9

Unvalidated antibodies and misleading results.

Rimm D, Schalper K, Pusztai L. Rimm D, et al. Breast Cancer Res Treat. 2014 Sep;147(2):457-8. doi: 10.1007/s10549-014-3061-0. Epub 2014 Aug 3. Breast Cancer Res Treat. 2014. PMID: 25086631 Free PMC article. No abstract available.

10

Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic.

Carvajal-Hausdorf DE, Schalper KA, Neumeister VM, Rimm DL. Carvajal-Hausdorf DE, et al. Among authors: schalper ka. Lab Invest. 2015 Apr;95(4):385-96. doi: 10.1038/labinvest.2014.157. Epub 2014 Dec 15. Lab Invest. 2015. PMID: 25502176 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters